• Profile
Close

Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: The ANDROMEDA-SHOCK randomized clinical trial

JAMA Feb 22, 2019

Hernández G, et al. - In this randomized clinical trial of 424 patients with early septic shock, researchers assessed mortality relative to a resuscitation strategy focusing on normalization of capillary refill time vs a strategy focusing on serum lactate levels. Out of the overall study population (mean age, 63 years; 226 [53%] women), the trial was completed by 416 (98%) patients. The intervention period ran for 8 hours, during which 212 patients randomly received a step-by-step resuscitation protocol aimed at normalizing capillary refill time and 212 were randomized to protocol aimed at normalizing or decreasing lactate levels at rates more than 20% per 2 hours. They found that the peripheral perfusion–targeted resuscitation group and the lactate level–targeted resuscitation group had 28-day mortality of 34.9% and 43.4%, respectively, which was not a statistically significant difference. Overall, no attenuation in all-cause 28-day mortality was seen with a resuscitation strategy targeting normalization of capillary refill time vs a strategy targeting serum lactate levels in this patient populace.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay